We are delighted to announce the grant of our patent in Japan.

The technology, aimed at ultrasound-guided interventional procedures, such as cancer biopsy and regional anaesthesia, allows accurate placement of needle in deep target locations.

Previous
Previous

Active Needle Technology Ltd.'s licensed patent, licensed from the University of Dundee, has been granted in Europe.

Next
Next

Active Needle Technology Ltd. is excited to announce the latest pre-clinical news about its HyPerfuse Needle™.